BSX FY 2023 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14.2B+12.3% YoY

Gross Profit

$8.8B62.0% margin

Operating Income

$2.2B15.3% margin

Net Income

$1.6B11.2% margin

EPS (Diluted)

$1.07

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$1.7B

Stock-Based Comp.

$233M

Balance Sheet

Total Assets

$35.1B

Total Liabilities

$15.6B

Stockholders' Equity

$19.3B

Cash & Equivalents

$865M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14.2B	$12.7B	+12.3%
Gross Profit	$8.8B	$7.7B	+14.5%
Operating Income	$2.2B	$1.8B	+19.6%
Net Income	$1.6B	$698M	+128.2%